NCT00713726

Brief Summary

In newborn infants submitted to surgical procedures, tramadol may provide an effective analgesia and decrease the time on mechanical ventilation support and the time to achieve full enteral feeding.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P25-P50 for phase_3 pain

Timeline
Completed

Started Jan 2006

Typical duration for phase_3 pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2006

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2008

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

July 9, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 11, 2008

Completed
Last Updated

July 11, 2008

Status Verified

July 1, 2008

Enrollment Period

2.5 years

First QC Date

July 9, 2008

Last Update Submit

July 10, 2008

Conditions

Keywords

PainAnalgesiaNewborn InfantOpioidsSide-effectsIntensive carePostoperative

Outcome Measures

Primary Outcomes (1)

  • Pain assessment wuth CRIES and NFCS pain scales during the first 72 hours after surgical procedure

    Every 2-4h during the first 72 hours after surgical procedure

Secondary Outcomes (2)

  • Time between surgical procedure and successful extubation

    Hospital stay

  • Time between surgical procedure and achievement of 100 mL/kg of enteral feeding

    hospital stay

Study Arms (2)

F

ACTIVE COMPARATOR

Patients that received continued infusion of fentanyl at a steady dose for the first 48 hours and, then, doses were gradually decreases until stop

Drug: FentanyL

T

EXPERIMENTAL

Patients that received continued infusion of tramadol at a steady dose for the first 48 hours and, then, doses were gradually decreases until stop

Drug: Tramadol

Interventions

Fentanyl: 1 µg/kg/h for preterm infants and 2 µg/kg/h for term infants for 48 hours and than gradually decrease until interruption of the drug.

F

Tramadol: 0.1 mg/kg/h for preterm infants and 0.2 mg/kg/h for term infants for 48 hours and than gradually decrease until interruption of the drug.

T

Eligibility Criteria

AgeUp to 28 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Infant 0-28 days of life with indication of large or medium surgical procedure (definition according to the American College of Cardiology, American Heart Association - 2002)

You may not qualify if:

  • Death or hospital discharge until 72 hours after surgical procedure
  • New surgery until 72 hours after the studied surgical procedure
  • Proved bacterial infection before surgery
  • Ambiguous genitalia
  • Chromosomal syndromes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Albert Sabin Hospital

Fortaleza, Ceará, 60.410.790, Brazil

Location

Related Publications (1)

  • Alencar AJ, Sanudo A, Sampaio VM, Gois RP, Benevides FA, Guinsburg R. Efficacy of tramadol versus fentanyl for postoperative analgesia in neonates. Arch Dis Child Fetal Neonatal Ed. 2012 Jan;97(1):F24-9. doi: 10.1136/adc.2010.203851. Epub 2011 Apr 5.

MeSH Terms

Conditions

PainAgnosia

Interventions

FentanylTramadol

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

PiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsCyclohexanolsHexanolsFatty AlcoholsAlcoholsOrganic ChemicalsDimethylaminesMethylaminesAminesLipids

Study Officials

  • Ruth Guinsburg, MD

    Federal University of São Paulo

    STUDY DIRECTOR
  • Ana Julia C Alencar

    Federal university of são Paulo and Albert Sabin Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 9, 2008

First Posted

July 11, 2008

Study Start

January 1, 2006

Primary Completion

July 1, 2008

Study Completion

July 1, 2008

Last Updated

July 11, 2008

Record last verified: 2008-07

Locations